Revista nº 811

Neumonía adquirida en pacientes graves de UCI | Serrano Ferrer C, et al. Actual Med. 2020; 105(811): 160- 166 166 5. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K,  et al. Diagnosis and treatment of adults with community acquired pneumonia. An official clini- cal practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Res- pir Crit Care Med. 2019; 200: e45– 67. doi: 10.1164/rcc- m.201908-1581ST. 6. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. The British Thoracic Society guidelines for the management of community acquired pneumonia in adults. Update 2009. Thorax. 2009; 64(Suppl 3):iii1–iii55. doi: 10.1136/thx.2009.121434 7. Arancibia F, Orlando P. Neumonía grave del adulto adquirida en la comunidad. Rev Chil Enferm Respir.  2005;  21( 2 ): 111-116. doi: 10.4067/S0717-73482005000200007 8. Woodhead M, Welch CA, Harrison DA, Bellingan G, Ayres JG. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care. 2006; 10(Suppl 2):S1. doi: 10.1186/cc4927. 9. Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-ac- quired pneumonia is associated with higher mortality. Chest. 2010;137(3):552-7. doi: 10.1378/chest.09-1547 10. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jac- quier JM, et al. A five-year study of severe community-ac- quired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med. 1995;21(1):24-31. doi: 10.1007/BF02425150. 11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 41(2):580- 637. doi: https://doi.org/10.1097/CCM.0b013e31827e83af. 12. Menendez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, et al. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J. 2012;39(1):156-62. doi: 10.1183/09031936.00188710. 13. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circu- lation. 2012; 125(6):773-81. doi: 10.1161/CIRCULATIONA- HA.111.040766. 14. Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, To- rres A. Microbial Etiology of Pneumonia: Epidemiology, Diag- nosis and Resistance Patterns. Int J Mol Sci. 2016;17:2120. doi: 10.3390/ijms17122120. 15. Letourneau AR, Issa NC, Baden LR. Pneumonia in the immu- nocompromised host. Curr Opin Pulm Med. 2014;20:272-9. doi: https://doi.org/10.1097/MCP.0000000000000051. 16. Patel M, Dennis A, Flutter C, Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth. 2010;104(2):128–142. doi: 10.1093/bja/aep375 17. Khalid I, Alraddadi BM, Dairi Y, Khalid TJ, Kadri M, Als- hukairi AN, et al. Acute management and long-term sur- vival among subjects with severe middle-east respiratory syndrome coronavirus pneumonia and ARDS. Respir Care. 2016;61(3):340–348. doi: 10.4187/respcare.04325. 18. Gadsby NJ, Russell CD, McHugh MP, Mark H, Morris AC, Laurenson IF, et al. Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin Infect Dis. 2016;62:817-23. doi: 10.1093/cid/civ1214. 19. Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al. A prospective comparison of severity scores for identifying patients with severe community-ac- quired pneumonia: reconsidering what is meant by seve- re pneumonia. Thorax. 2006; 61:419–424. doi: 10.1136/ thx.2005.051326. 20. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al. SMART-COP: a tool for predicting the need for inten- sive respiratory or vasopressor support in community-ac- quired pneumonia. Clin Infect Dis. 2008;47:375–384. doi: 10.1086/589754. 21. Chalmers JD. Mandal P, Singanayagam A, Akram AR, Choud- hury G, Short PM, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: syste- matic review and meta-analysis. Intensive Care Med. 2011 Sep;37(9):1409-20. doi: 10.1007/s00134-011-2261-x. 22. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acu- te hypoxemic respiratory failure. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: https://doi.org/10.1056/NEJ- Moa1503326. 23. Li G, Cook DJ, Thabane L, Friedric JO, Crozier TM, Musced- ere J, et al. Risk factors for mortality in patients ad- mitted to intensive care units with pneumonia. Respir Res. 2016;17(1):80. doi: 10.1186/s12931-016-0397-5. Los autores/as de este artículo declaran no tener nin- gún tipo de conflicto de intereses respecto a lo ex- puesto en el presente trabajo. CONFLICTO DE INTERESES Si desea citar nuestro artículo: Serrano Ferrer C, Higuera Lucas J, Ruiz García A, Trascasa Muñoz M, Llorente Ruiz B, López Ramos E, Nevado Losada E. Caracterización de la neumonía adquirida en la comunidad grave en la UCI. Estudio retrospectivo de 2 años. Actual Med. 2020;811(105):160-166. DOI: 10.15568/am.2020.811.or02